As of Oct 02
| 0.00 / 0.00%|
InoLife Technologies, Inc. operates as a development stage service based healthcare product marketing company. The company currently market: a DNA testing for Plavix; pre disposition screening for certain genetic diseases, and ancestry and paternity tests. The principal users of products include healthcare providers including physicians, hospitals, and outpatient facilities, in addition to individuals with a direct need for the solutions. The company's products will be sold directly to consumers through e-commerce, direct sales, pharmacies, retailers, distributors and healthcare providers. InoLife Technologies was founded on November 12, 1998 and is headquartered in New York, NY.
|Elizabeth A. Cirone||Chief Executive Officer|